Transforming growth factor-β1 downregulates tryptophanyl-tRNA synthetase expression in human lung fibroblasts
Advances in Medical Sciences · 2026-03 · 71 (1) · 56-60
DOI: 10.1016/j.advms.2026.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medical Sciences, 2026-03. Verfasst von Aaron K McDowell-Sanchez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, United States. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Fibroblasts, Lung, Down-Regulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
PURPOSE: The role of tryptophanyl-tRNA synthetase, also known as WARS, in lung fibroblasts is currently unknown. We aimed to study the effect of transforming growth factor-beta 1 (TGF-β1) on the expression of WARS and whether it regulates profibrotic responses in TGF-β1-activated human lung fibroblasts. MATERIALS AND METHODS: We used MRC-5, a human lung fibroblast cell line, and primary human lung fibroblasts (HLFs) derived from control subjects. WARS expression was measured by enzyme-linked immunosorbent assay (ELISA) and Western blot. Profibrotic responses in TGF-β1-stimulated human lung fibroblasts were measured by Western blot, gel contraction assay, and real-time quantitative PCR (RT-qPCR). RESULTS: We demonstrate that TGF-β1 potently downregulates WARS expression, both at the extracellular and intracellular levels, in MRC-5, and HLFs. Yin Yang 1 (YY1) transcription factor (TF) silencing ameliorates the inhibitory effect of TGF-β1 on WARS expression. Finally, we found that recombinant (r) WARS significantly inhibited fibronectin (FN) but had no effect on collagen1 (COL1) or alpha-smooth muscle actin (αSMA) expression in TGF-β1-induced HLFs. CONCLUSIONS: Our results demonstrate that TGF-β1 inhibits WARS expression via YY1, however, WARS treatment has a modest effect on regulating profibrotic responses in activated HLFs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, United States.
- Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, United States; Department of Medicine, Division of Pulmonary and Critical Care, University of Marylan…
Förderung
- NIAMS NIH HHS
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
McDowell-Sanchez, A. K., & Tsoyi, K. (2026). Transforming growth factor-β1 downregulates tryptophanyl-tRNA synthetase expression in human lung fibroblasts. Advances in Medical Sciences, 71(1), 56-60. https://doi.org/10.1016/j.advms.2026.02.002
Vancouver
McDowell-Sanchez AK, Tsoyi K. Transforming growth factor-β1 downregulates tryptophanyl-tRNA synthetase expression in human lung fibroblasts. Advances in Medical Sciences. 2026;71(1):56-60. doi:10.1016/j.advms.2026.02.002
BibTeX
@article{McDowellSanchez2026,
author = {McDowell-Sanchez, Aaron K and Tsoyi, Konstantin},
title = {Transforming growth factor-β1 downregulates tryptophanyl-tRNA synthetase expression in human lung fibroblasts},
journal = {Advances in Medical Sciences},
year = {2026},
volume = {71},
number = {1},
pages = {56--60},
doi = {10.1016/j.advms.2026.02.002}
}
EUVIMED